PH12015502154A1 - Composition for oral cavity - Google Patents

Composition for oral cavity

Info

Publication number
PH12015502154A1
PH12015502154A1 PH12015502154A PH12015502154A PH12015502154A1 PH 12015502154 A1 PH12015502154 A1 PH 12015502154A1 PH 12015502154 A PH12015502154 A PH 12015502154A PH 12015502154 A PH12015502154 A PH 12015502154A PH 12015502154 A1 PH12015502154 A1 PH 12015502154A1
Authority
PH
Philippines
Prior art keywords
composition
oral cavity
oxo
component
acid
Prior art date
Application number
PH12015502154A
Other versions
PH12015502154B1 (en
Inventor
Oniki Takayuki
Inoue Shimako
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of PH12015502154A1 publication Critical patent/PH12015502154A1/en
Publication of PH12015502154B1 publication Critical patent/PH12015502154B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Provided is a composition for the oral cavity, said composition exerting a high anti-inflammatory effect and having an excellent formulation stability. The composition for the oral cavity comprises: component (A) that is one or more kinds of lactam compounds selected from the group consisting of pyrrolidonecarboxylic acid, 6-oxo-2-piperidinecarboxylic acid, 3-(2-oxo-1-azepanyl)propanoic acid and salts thereof; and component (B) that is an anti-inflammatory agent.
PH12015502154A 2013-03-27 2015-09-15 Composition for oral cavity PH12015502154B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013067202 2013-03-27
PCT/JP2014/058940 WO2014157547A1 (en) 2013-03-27 2014-03-27 Composition for oral cavity

Publications (2)

Publication Number Publication Date
PH12015502154A1 true PH12015502154A1 (en) 2016-01-25
PH12015502154B1 PH12015502154B1 (en) 2016-01-25

Family

ID=51624505

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12015502154A PH12015502154B1 (en) 2013-03-27 2015-09-15 Composition for oral cavity

Country Status (6)

Country Link
JP (1) JP6425648B2 (en)
KR (1) KR102191271B1 (en)
CN (1) CN105142607B (en)
MY (1) MY174149A (en)
PH (1) PH12015502154B1 (en)
WO (1) WO2014157547A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6615007B2 (en) * 2016-03-03 2019-12-04 ライオン株式会社 Oral composition
CN105796379A (en) * 2016-05-06 2016-07-27 青岛蓝百合生物科技有限公司 Water soluble chitosan oral care solution and preparation method thereof
CN107519182A (en) * 2016-06-20 2017-12-29 天津金耀集团有限公司 Dermopharmaceutical composition using butyric acid hydrocortisone as active component
KR102579556B1 (en) 2016-09-02 2023-09-18 라이온 가부시키가이샤 Oral composition
CN107802641A (en) * 2016-09-09 2018-03-16 李明典 Oral soft tissue (gum, mucous membrane) anti-inflammatory is ached agent
JP6535146B1 (en) * 2019-03-08 2019-06-26 佐藤製薬株式会社 Skin barrier function improver
CN118076334A (en) * 2021-10-12 2024-05-24 狮王株式会社 Oral composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09291018A (en) 1996-04-25 1997-11-11 Sunstar Inc Composition for oral cavity
JP2000229823A (en) * 1999-02-05 2000-08-22 Lion Corp Composition for oral cavity
DE60207020D1 (en) * 2001-08-21 2005-12-08 Ajinomoto Kk Bactericidal guanidine derivatives, dermal compositions, washing compositions and antibacterial fiber aggregates
JP2004131383A (en) * 2002-06-25 2004-04-30 Lion Corp Sheetlike pack
WO2005009454A1 (en) * 2003-07-29 2005-02-03 Hououdou Co., Ltd. Periodontal disease therapeutic and/or preventive composition
KR20090086433A (en) * 2006-11-14 2009-08-12 선스타 가부시키가이샤 Oral composition containing crystalline cellulose surface-treated with water-soluble substance
JP2008156308A (en) * 2006-12-26 2008-07-10 Lion Corp Composition for oral cavity
JP2009126819A (en) * 2007-11-22 2009-06-11 Vmc Co Ltd Dental whitening agent and dental whitening method
JP5893249B2 (en) * 2010-01-29 2016-03-23 サンスター株式会社 Oral composition
JP5804307B2 (en) * 2010-03-03 2015-11-04 サンスター株式会社 Oral composition
WO2012073601A1 (en) * 2010-11-30 2012-06-07 ライオン株式会社 Inhibitor of attachment of periodontal-disease-inducing bacterium onto surfaces of teeth, oral biofilm formation inhibitor, and composition for oral applications

Also Published As

Publication number Publication date
WO2014157547A1 (en) 2014-10-02
JP6425648B2 (en) 2018-11-21
CN105142607A (en) 2015-12-09
KR20150133705A (en) 2015-11-30
KR102191271B1 (en) 2020-12-15
CN105142607B (en) 2018-12-04
JPWO2014157547A1 (en) 2017-02-16
MY174149A (en) 2020-03-11
PH12015502154B1 (en) 2016-01-25

Similar Documents

Publication Publication Date Title
PH12015502154A1 (en) Composition for oral cavity
NZ716840A (en) Combination formulation of two antiviral compounds
WO2016105564A8 (en) Quinazoline derivatives used to treat hiv
WO2014144545A3 (en) Substituted benzoxazoles and methods of use thereof
PH12018500061A1 (en) Oxysterols and methods of use thereof
GEP201606555B (en) Compounds and compositions for modulating egfr activity
MX2017008518A (en) Isoquinoline compounds for the treatment of hiv.
TN2017000521A1 (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
NZ705213A (en) C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
EP4316591A3 (en) Oxysterols and methods of use thereof
MX366913B (en) C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof.
PH12015502802A1 (en) Formulation comprising a hypolipidemic agent
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
PH12016501034A1 (en) Oral care compositions and methods
MX2015015562A (en) Dihydropyridinone mgat2 inhibitors.
PH12016500347A1 (en) Triazolopyridine compounds, compositions and methods of use thereof
MX2015016332A (en) Pyrrolotriazines as alk inhibitors.
MA37650A1 (en) Amorphous form of an akt-inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof
PH12015502211A1 (en) Oral composition
MX358871B (en) Oral care compositions and methods.
MX354226B (en) Oral care compositions and methods.
WO2014166836A8 (en) Growth hormone compound formulation
WO2014145314A3 (en) Methods and compositions for gamma-glutamyl cycle modulation
EP3459933A3 (en) Solid forms of a pharmaceutically active compound
MX2016008234A (en) Oral care compositions and methods.